Top of page
Global Site Navigation

School of Medical and Health Sciences

Local Section Navigation
You are here: Main Content

Dr Prashant Bharadwaj

Post Doctoral Fellow

Contact Information Telephone: +61 8 6304 2234, Mobile: 0433579575, Email:, Campus: Joondalup, Room: JO17.108
Staff Member Details
Telephone: +61 8 6304 2234
Mobile: 0433579575
Campus: Joondalup  
Room: JO17.108  


Prashant is a Post Doctoral Research Fellow in Neuroscience within the School of Medical and Health Sciences.


  • April 2016-present: NHMRC-ARC Dementia Research Development Fellow, Edith Cowan University, WA, Australia
  • April 2016-present: Adjunct Research Fellow, School of Biomedical Sciences, CHIRI Biosciences Research Precinct, Curtin University, WA, Australia
  • April 2015- Mar 2016: Research Associate, School of Biomedical Sciences, CHIRI Biosciences Research Precinct, Curtin University, WA, Australia
  • Dec 2011- present: Postdoctoral Research Fellow, School of Medical Sciences, Edith Cowan University, WA, Australia

Professional Associations

  • 2010-2011: The Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART)
  • 2009-2010: Australian Society for Medical Research
  • 2007-2008: The Australian Society of Microbiology
  • 2007- present: Australasian Yeast Group:

Awards and Recognition


  • 2008-2011: Full time PhD Scholarship and Tuition Fee Waiver: Centre of Excellence for Alzheimer’s Disease Research and Care, School of Exercise, Biomedical and Health Sciences, Faculty of Computing Health Sciences, Edith Cowan University
  • 2009-2011: PhD Top-up Scholarship: CSIRO, Material Science and Engineering, Parkville, Victoria, Preventive Health Flagship
  • 2010: CSIRO Preventive Health Flagship Travel Award (International Conference on Alzheimer’s Disease, Hawaii)

Research Areas and Interests

  • Alzheimer’s disease
  • Beta amyloid protein
  • Autophagy
  • Neuroprotective genes


  • Doctor of Philosophy, Edith Cowan University, 2011.
  • Master of Biotechnology, Royal Melbourne Institute of Technology, 2007.
  • Bachelor of Engineering, India, 2004.


Recent Research Grants

  • Neuroprotective functions of autophagy regulators in Alzheimer's disease,  National Health and Medical Research Council,  Dementia Research Development Fellowship,  2016 - 2021,  $640,220.
  • Short chain fatty acids are a useful therapy for the treatment of Alzheimer's Disease. ,  Hollywood Private Hospital Research Foundation,  Grant,  2013 - 2016,  $20,000.
  • Targeting chaperone mediated autophagy to alleviate Aβ accumulation and toxicity in AD ,  Dementia Australia Research Foundation,  AADRF - Dementia Grants Program,  2015 - 2016,  $50,000.
  • Effects of Latrepirdine on beta amyloid clearance, aggregation and neurodegeneration in Alzheimer’s disease,  Australian Alzheimer's Research Foundation,  Australian Alzheimer's Research Foundation - Sponsorship,  2014 - 2015,  $12,555.
  • Protective role of autophagy genes in Alzheimer’s disease,  Edith Cowan University,  ECU Early Career Researcher Grant - 2014,  2014,  $10,000.

Recent Publications (within the last five years)

Journal Articles

  • Bharadwaj, P., Martins, R., (2020), PRKAG2 Gene Expression Is Elevated and its Protein Levels Are Associated with Increased Amyloid-B Accumulation in the Alzheimer’s Disease Brain. Journal of Alzheimer's Disease, 74(2), 441-448, Netherlands, IOS Press, DOI: 10.3233/JAD-190948.
  • Bharadwaj, P., Martins, R., (2020), A rapid absorbance-based growth assay to screen the toxicity of oligomer Aβ42 and protect against cell death in yeast. Neural Regeneration Research, 15(10), 1931-1936, DOI: 10.4103/1673-5374.280318.
  • Mputhia, Z., Hone, E., Tripathi, T., Sargeant, T., Martins, R., Bharadwaj, P., (2019), Autophagy Modulation as a Treatment of Amyloid Diseases. Molecules, 24(18), Article 3372, DOI: 10.3390/molecules24183372.
  • Tripathi, T., Kalita, P., Martins, R., Bharadwaj, P., (2019), Autophagy promotes memory function. ACS Chemical Neuroscience, 10(8), 3337-3339, DOI: 10.1021/acschemneuro.9b00317.
  • Martins, R., Villemagne, V., Sohrabi, H., Chatterjee, P., Shah, T., Verdile, G., Fraser, P., Taddei, K., Gupta, V., Rainey-Smith, S., Hone, E., Pedrini, S., Lim, F., Martins, I., Frost, S., Gupta, S., O'Bryant, S., Rembach, A., Ames, D., Ellis, K., Fuller, S., Brown, B., Gardener, S., Fernando, B., Bharadwaj, P., Burnham, S., Laws, S., Barron, A., Goozee, K., Wahjoepramono, EJ., Asih, P., Doecke, J., Salvado, O., Bush, A., Rowe, C., Gandy, S., Masters, C., (2018), Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies. Journal of Alzheimer's Disease, 62(3), 965-992, Netherlands, IOS Press, DOI: 10.3233/JAD-171145.
  • Bharadwaj, P., Solomon, T., Malajczuk, C., Mancera, R., Howard, M., Arrigan, D., Newsholme, P., Martins, R., (2018), Role of the cell membrane interface in modulating production and uptake of Alzheimer's beta amyloid protein. BBA: Biomembranes, 1860(9), 1639-1651, Netherlands, Elsevier, DOI: 10.1016/j.bbamem.2018.03.015.
  • Moore, S., Sonar, K., Bharadwaj, P., Deplazes, E., Mancera, R., (2018), Characterisation of the structure and oligomerisation of islet amyloid polypeptides (IAPP). Molecules, 23(9), article no.2142, NA, MDPI AG, DOI: 10.3390/molecules23092142.
  • Bharadwaj, P., Wijesekara, N., Liyanapathirana, M., Newsholme, P., Ittner, L., Fraser, P., Verdile, G., (2017), The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-B, Amylin, and Tau Proteins. Journal of Alzheimer's Disease, 59(2), 421-432, Netherlands, IOS Press, DOI: 10.3233/JAD-161192.
  • Porter, T., Bharadwaj, P., Groth, D., Paxman, A., Laws, S., Martins, R., Verdile, G., (2016), The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity. Journal of Alzheimer's Disease, 50(3), 895-905, Netherlands, IOS Press, DOI: 10.3233/JAD-150790.

Research Student Supervision

Associate Supervisor

  • Doctor of Philosophy,  Investigation of the role of amla in modulating cholesterol metabolism, and understanding its mechanism of action in reducing alzheimer's risk
Skip to top of page